Stocktoria

Voyager Therapeutics, Inc. VYGR

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-11-11 · LEI

Voyager Therapeutics, Inc. statistics & valuation

Market cap$213.3M
P / S5.3×
P / B1.1×
Net margin-296.5%
Return on equity-61.1%
FCF margin-334.5%
Return on capital-58.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-282.70% -697.60% -1158.80% -41.80% 21.50% -190.30% -113.40% 52.90% -81.30% -296.50% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-290.40% -709.10% -1195.60% -49.50% 16.00% -196.80% -124.30% 48.80% -104.10% -326.60% 2016201720182019202020212022202320242025
Return on equity (%)
-29.60% -52.70% -190.10% -43.80% 23.80% -74.90% -78.60% 56.00% -21.70% -61.10% 2016201720182019202020212022202320242025
Shares outstanding
25.6M 31.6M 32.4M 36.9M 37.4M 37.9M 38.6M 44.6M 57.7M 59.0M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-21.20% -38.30% -49.90% -12.30% 14.00% -36.70% -29.10% 37.70% -16.50% -47.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-334.10% -644.60% -265.00% 39.20% -63.60% -147.40% -36.70% 29.90% -23.50% -334.50% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$2.75 -$1.21 $0.98 -$1.89 -$1.21 $2.97 -$1.13 -$2.04 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-326.6%-104.1%48.8%-124.3%-196.8%16.0%-49.5%-1195.6%-709.1%-290.4%
Net margin-296.5%-81.3%52.9%-113.4%-190.3%21.5%-41.8%-1158.8%-697.6%-282.7%
FCF margin-334.5%-23.5%29.9%-36.7%-147.4%-63.6%39.2%-265.0%-644.6%-334.1%
Return on assets-47.5%-16.5%37.7%-29.1%-36.7%14.0%-12.3%-49.9%-38.3%-21.2%
Return on equity-61.1%-21.7%56.0%-78.6%-74.9%23.8%-43.8%-190.1%-52.7%-29.6%
Current ratio7.645.564.961.722.687.394.015.1310.8112.95

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.